Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fundamental study on hyperthermic chemotherapy using adriamycin-loaded hydroxyapatite].

S Nakatani1, K Kunieda, T Seki

  • 13rd Dept. of Internal Medicine, Kansai Medical University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|August 1, 1992
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ion channels on synaptic vesicle membranes studied by planar lipid bilayer method.

Biophysical journal·1992
Same author

Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study.

Liver·1992
Same author

Roles of Ca2+ influx through ATP-activated channels in catecholamine release from pheochromocytoma PC12 cells.

Journal of neurophysiology·1992
Same author

Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor.

Endocrinology·1992
Same author

An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats.

The Journal of nutrition·1992
Same author

[Selection of methods for diagnosis and treatment of pancreatic cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1992

This study introduces ADM-HAP, a novel drug delivery system that gradually releases adriamycin (ADM). Hyperthermia combined with ADM-HAP synergistically inhibits tumor growth by localized drug release and targeted heating.

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Oncology

Context:

  • Developing innovative cancer therapies is crucial.
  • Adriamycin (ADM) is a potent chemotherapy drug with limitations in targeted delivery.
  • Hydroxyapatite ceramic (HAP) offers potential as a biocompatible drug carrier.

Purpose:

  • To develop a novel drug delivery system (DDS) using porous hydroxyapatite ceramic (HAP) incorporating adriamycin (ADM), termed ADM-HAP.
  • To investigate the potential of ADM-HAP for hyperthermic chemotherapy.
  • To evaluate the in vitro and in vivo efficacy of ADM-HAP in combination with hyperthermia.

Summary:

  • ADM-HAP demonstrated controlled, gradual release of ADM over 30 days.
  • In vitro studies showed increased ADM release at elevated temperatures (42.5-44°C).

Related Experiment Videos

  • In vivo experiments using Sarcoma 180 tumor models in mice revealed synergistic tumor growth inhibition with hyperthermia and ADM-HAP compared to ADM alone.

    • Impact:

    • Successful development of ADM-HAP as a localized hyperthermic chemotherapy delivery system.
    • Demonstrated synergistic tumor growth inhibition through targeted ADM release and localized hyperthermia.
    • Potential for enhanced cancer treatment efficacy with reduced systemic side effects.